PLA2G4C Peptide

• NCBI Gene ID:

  8605

• Swiss Prot:

  Q9UP65

• Accession Number:

  NP_003697.2, NP_001152794.1, NP_001152795.1

• Type:

  Peptides

• Buffer:

  PLA2G4C peptide is supplied as 100 μ g of dried peptide. When the peptide is reconstituted in 200 μ L water, the concentration will be 0.5 mg/mL.

• Shipping Conditions:

  Room Temp

• Storage Conditions:

  Store at -20˚ C. When reconstituted minimize freezing and thawing.

• Applications Notes:

  PLA2G4C peptide is used for blocking the activity of PLA2G4C antibody (catalog number 43-261) . The PLA2G4C antibody ships at 0.5 mg/mL and the STK36 Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed) . Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide..

• NCBI Official Name:

  Phospholipase A2 group IVC

• NCBI Organism:

  Homo sapiens

• Other Product Names:

  PLA2G4C, phospholipase A2, group IVC (cytosolic, calcium-independent), CPLA2-gamma, DKFZp586C0423, FLJ42247, FLJ44164, cytosolic phospholipase A2 gamma, phospholipase A2, cytosolic, calcium-independent, gamma, phospholipase A2, group IVC

• Tested Applications:

  Blocking

• Species:

  Human

• Protein ID:

  226693354

• Physical Properties:

  Lyophilized